News & Views

News and updates from our areas of work

Celebrating more progress in TB treatment

14 mai 2016 | Under News | Posted by

The World Health Organization has just approved a new, shorter MDR-TB regimen. This comes after the launch of new paediatric-appropriate TB drugs at the end of 2015 and constant work to improve case detection, treatment, routine monitoring and data collection on TB cases.

See an extract of the WHO press release below. The full release is available on the WHO website.

Rapid diagnostic test and shorter, cheaper treatment signal new hope for multidrug-resistant tuberculosis patients

News release

12 MAY 2016 | GENEVA – New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.

“This is a critical step forward in tackling the MDR-TB public health crisis,” said Dr Mario Raviglione, Director of WHO’s Global TB Programme. “The new WHO recommendations offer hope to hundreds of thousands of MDR-TB patients who can now benefit from a test that quickly identifies eligibility for the shorter regimen, and then complete treatment in half the time and at nearly half the cost.”